Your browser is no longer supported. Please, upgrade your browser.
ZSAN Zosano Pharma Corporation monthly Stock Chart
ZSAN [NASD]
Zosano Pharma Corporation
Index- P/E- EPS (ttm)-15.41 Insider Own1.97% Shs Outstand12.14M Perf Week0.66%
Market Cap55.48M Forward P/E- EPS next Y- Insider Trans-26.97% Shs Float11.74M Perf Month5.30%
Income-30.30M PEG- EPS next Q- Inst Own62.50% Short Float13.59% Perf Quarter-73.80%
Sales- P/S- EPS this Y61.20% Inst Trans- Short Ratio2.36 Perf Half Y-63.72%
Book/sh-0.52 P/B- EPS next Y- ROA-136.40% Target Price80.00 Perf Year-81.87%
Cash/sh- P/C- EPS next 5Y- ROE-287.20% 52W Range3.61 - 30.00 Perf YTD-56.06%
Dividend- P/FCF- EPS past 5Y-46.60% ROI- 52W High-84.77% Beta1.97
Dividend %- Quick Ratio0.50 Sales past 5Y- Gross Margin- 52W Low26.59% ATR0.26
Employees39 Current Ratio0.50 Sales Q/Q- Oper. Margin- RSI (14)59.31 Volatility5.31% 5.56%
OptionableNo Debt/Eq- EPS Q/Q39.60% Profit Margin- Rel Volume0.41 Prev Close4.57
ShortableYes LT Debt/Eq- EarningsMay 15 AMC Payout- Avg Volume674.57K Price4.57
Recom2.00 SMA206.99% SMA506.20% SMA200-56.85% Volume0 Change0.00%
Mar-24-17Initiated Piper Jaffray Overweight $4
Aug-11-16Downgrade Ladenburg Thalmann Buy → Neutral
Nov-11-15Reiterated ROTH Capital Buy $11 → $7
Sep-29-15Reiterated ROTH Capital Buy $20 → $11
Feb-23-15Initiated ROTH Capital Buy $20
May-31-18 08:20AM  Market Trends Toward New Normal in ANSYS, Pearson, Qualys, H. B. Fuller, Cabot Microelectronics, and Zosano Pharma Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
May-30-18 07:25AM  Complimentary Technical Snapshots on VIVUS and Three More Biotech Stocks ACCESSWIRE
May-23-18 08:30AM  Zosano Announces Publication of Most Bothersome Symptom Data from the ZOTRIP Pivotal Study in Headache: The Journal of Head and Face Pain GlobeNewswire
May-22-18 08:30AM  Zosano Appoints Steven A. Elms to Board of Directors GlobeNewswire
May-15-18 04:00PM  Zosano Pharma Reports First Quarter 2018 Financial Results and Operational Update GlobeNewswire
May-14-18 08:30AM  Zosano Reaches Another Enrollment Milestone in M207-ADAM Long-term Safety Study GlobeNewswire +10.54%
May-08-18 04:05PM  Zosano Pharma to Host Conference Call on First Quarter 2018 Financial Results and Provide Operational Update GlobeNewswire
Apr-05-18 08:15AM  Analysis: Positioning to Benefit within Euronet Worldwide, Innospec, Zosano Pharma, Ardelyx, Crown Castle International, and Aldeyra Therapeutics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Apr-03-18 04:05PM  Zosano Announces Closing of Public Offering of Common Stock GlobeNewswire
Apr-02-18 12:56PM  Zosano Pharma to Host Conference Call to Provide Operational Update GlobeNewswire
Mar-29-18 09:00AM  Zosano Announces Pricing of Public Offering of Common Stock GlobeNewswire -45.04%
08:17AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:37AM  Zosano Pharma's stock plummets after stock offering filed, assumed to price at deep discount MarketWatch
Mar-20-18 07:30AM  Wired News Zosano Reports Enrollment Milestone in its M207-ADAM Study ACCESSWIRE
Mar-16-18 11:02AM  Should You Buy Zosano Pharma Corporation (NASDAQ:ZSAN) Now? Simply Wall St. +12.52%
08:30AM  Zosano Reaches Enrollment Milestone in M207-ADAM Long-term Safety Study GlobeNewswire
Mar-12-18 08:45AM  Zosano Pharma Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Operational Update GlobeNewswire -10.78%
Mar-09-18 09:07AM  The Market In 5 Minutes: Trump And Kim Jung Un, Toys 'R' Us Liquidation, Zosano's Move, Big Payrolls Beat Benzinga -6.71%
Mar-08-18 07:30AM  Report: Developing Opportunities within Owens & Minor, Zosano Pharma, Organovo, Summit Materials, Ralph Lauren, and Clearside Biomedical Future Expectations, Projections Moving into 2018 GlobeNewswire +27.25%
Mar-05-18 08:10AM  Todays Research Reports on Stocks to Watch: Nektar Therapeutics and Zosano Pharma ACCESSWIRE
Mar-02-18 08:30AM  Zosano Pharma Announces Issuance of New U.S. Patent Covering M207 as an Acute Treatment for Migraine GlobeNewswire +39.38%
Feb-27-18 08:30AM  Todays Research Reports on Trending Tickers: Arrowhead Pharmaceuticals and Zosano Pharma ACCESSWIRE +7.94%
Jan-25-18 09:00AM  Zosano Announces Results of Special Meeting of Stockholders and 1-for-20 Reverse Stock Split GlobeNewswire -13.02%
Jan-03-18 08:30AM  Zosano Pharma Announces Notice of Allowance for a U.S. Patent Application Covering M207 as an Acute Treatment for Migraine GlobeNewswire +7.55%
Jan-02-18 01:29PM  Want To Invest In Zosano Pharma Corporation (NASDAQ:ZSAN)? Heres How It Performed Lately Simply Wall St.
Dec-26-17 04:04PM  Iconix, PPL Corp. Slip into Tuesdays 52-Week Low Club 24/7 Wall St. -9.28%
Dec-15-17 04:30PM  Zosano Announces Resignation of Bruce Steel from Board of Directors GlobeNewswire +6.12%
Nov-21-17 12:39PM  Is Zosano Pharma Corporation (ZSAN) A Financially Sound Company? Simply Wall St. -8.82%
Nov-15-17 09:00AM  Zosano Pharma to Present at 29th Annual Piper Jaffray Healthcare Conference GlobeNewswire +7.69%
Nov-09-17 04:05PM  Zosano Pharma Reports Third Quarter 2017 Financial Results and Operational Update GlobeNewswire
Nov-08-17 08:30AM  Zosano Pharma Announces Initiation of Long-Term Safety Study for M207 as an Acute Treatment of Migraine GlobeNewswire
Nov-01-17 08:30AM  Zosano Pharma to Host Conference Call on Third Quarter 2017 Financial Results and Provide Operational Update GlobeNewswire +12.54%
Oct-20-17 04:15PM  Zosano Enters into Common Stock Purchase Agreement with Lincoln Park Capital GlobeNewswire
Oct-12-17 02:43PM  Zosano Announces Publication of Pivotal Data of ADAM Zolmitriptan for the Acute Treatment of Migraine in Cephalalgia GlobeNewswire +5.61%
Oct-11-17 08:00AM  Today's Research Reports on Trending Tickers: Insys Therapeutics and Zosano Pharma Corporation ACCESSWIRE +11.46%
Oct-04-17 09:00AM  Zosano Appoints Kenneth Greathouse to Board of Directors GlobeNewswire
Sep-26-17 05:03PM  Zosano Provides Patent Application Update GlobeNewswire -5.93%
Sep-13-17 11:36AM  Zosano Presents Data from ZOTRIP Study at International Headache Society GlobeNewswire +10.31%
Aug-28-17 08:30AM  Zosano Pharma Announces US Patent Office Publication of Method of Rapidly Achieving Therapeutic Concentrations of Triptans for Treatment of Migraines GlobeNewswire
Aug-10-17 04:01PM  Zosano Pharma Reports Second Quarter 2017 Financial Results and Operational Update GlobeNewswire -5.05%
03:30PM  Investor Network: Zosano Pharma Corp. to Host Earnings Call ACCESSWIRE
Aug-02-17 08:30AM  Zosano Pharma to Host Conference Call on Second Quarter 2017 Financial Results and Provide Operational Update GlobeNewswire
Jul-31-17 09:30AM  Zosano Announces Publication of Positive Phase 1 Data of Zolmitriptan Delivery In Future Medicines Pain Management Journal GlobeNewswire
Jun-26-17 08:30AM  Zosano Pharma Announces Outcome of End of Phase 2 Meetings with FDA GlobeNewswire
Jun-14-17 04:01PM  Zosano Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Jun-12-17 08:30AM  Zosano Presents Additional Data from ZOTRIP Study at American Headache Society, Demonstrating Positive Results for Pain Freedom and Sustained Pain Freedom GlobeNewswire -9.33%
Jun-01-17 08:30AM  Zosano to Present Migraine Data at Three Industry-Leading Conferences GlobeNewswire
May-30-17 08:00AM  Today's Research Reports on Stocks to Watch: BioDelivery Sciences International and Zosano Pharma Accesswire
May-26-17 11:15PM  Zosano Pharma Corp (ZSAN) Interim CEO John Peter Walker Bought $100,254 of Shares GuruFocus.com +12.03%
May-09-17 04:00PM  Zosano Reports First Quarter 2017 Financial Results and Announces Management Changes GlobeNewswire
03:05PM  Investor Network: Zosano Pharma Corp. to Host Earnings Call Accesswire
May-08-17 05:30AM  Zosano Pharma to Host Conference Call on First Quarter 2017 Financial Results and Provide Operational Update GlobeNewswire
Apr-17-17 09:20AM  5 Drug Stocks That Could Be Big Winners this Earnings Season Zacks
Apr-04-17 09:47AM  Shkreli Gives Zosano a Giant Headache Investopedia -10.38%
09:47AM  Shkreli Gives Zosano a Giant Headache
Mar-31-17 12:00PM  Penny Stocks to Watch for April 2017 (ATRS, WRN) at Investopedia
Mar-22-17 04:01PM  Zosano Announces Closing of Public Offering of Common Stock and Exercise of Underwriters Over-Allotment Option GlobeNewswire
Mar-17-17 09:25AM  Zosano Announces Pricing of Public Offering of Common Stock GlobeNewswire -9.88%
08:55AM  ZOSANO PHARMA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Mar-07-17 01:04PM  ZOSANO PHARMA CORP Financials -5.53%
Mar-02-17 05:21PM  Penny Stocks to Watch for March 2017 (MOBL) Investopedia
05:21PM  Penny Stocks to Watch for March 2017 (MOBL)
Mar-01-17 07:31AM  ZOSANO PHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
07:00AM  Zosano Pharma Reports Fourth Quarter and Fiscal 2016 Financial Results and Business Update GlobeNewswire
06:16AM  ZOSANO PHARMA CORP Files SEC form 10-K, Annual Report
Feb-16-17 09:30AM  Biotech Industry Shaping up to Have a Breakout Year in 2017: Today's Reports on Insys Therapeutics and Zosano Pharma Accesswire +7.72%
Feb-14-17 10:47AM  Zosano Pharma Corp (ZSAN) Is Playing With The Big Boys In The Migraine Space Insider Monkey +18.82%
10:47AM  Zosano Pharma Corp (ZSAN) Is Playing With The Big Boys In The Migraine Space at Insider Monkey
Feb-13-17 04:20PM  ZOSANO PHARMA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits +41.67%
11:10AM  Can Zosano Pharma Turn Itself Around With This Late-Stage Migraine Trial Win? 24/7 Wall St.
11:10AM  Can Zosano Pharma Turn Itself Around With This Late-Stage Migraine Trial Win?
10:36AM  Fear of Missing Out Is Building TheStreet.com
10:36AM  Fear of Missing Out Is Building
09:56AM  Zosana Pharma's stock rockets after migraine patch produces positive trial results at MarketWatch
08:30AM  Zosano Pharma Announces 3.8mg Dose of M207, its Novel Transdermal Therapeutic, Meets Both Co-primary Endpoints in the ZOTRIP Pivotal Efficacy Trial in Migraine GlobeNewswire
Jan-25-17 04:37PM  ZOSANO PHARMA CORP Files SEC form 8-K, Other Events
Jan-23-17 05:18PM  Zosano Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Jan-05-17 08:30AM  Zosano Pharma Announces Last Subject Treated in its Migraine Pivotal Trial GlobeNewswire +11.47%
Nov-22-16 05:16PM  ZOSANO PHARMA CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -7.28%
05:00PM  Zosano Pharma Announces Sale of Non-Strategic Asset GlobeNewswire
Nov-09-16 04:35PM  ZOSANO PHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
04:20PM  Zosano Pharma Reports Third Quarter 2016 Financial Results GlobeNewswire
Nov-08-16 08:30AM  Zosano Pharma Announces Completion of Enrollment in Pivotal Efficacy Trial for M207 for Acute Migraine GlobeNewswire
Nov-03-16 04:15PM  ZOSANO PHARMA CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -16.52%
Oct-14-16 04:10PM  ZOSANO PHARMA CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
Oct-05-16 08:35PM  SHAREHOLDER NOTICE: Khang & Khang LLP Announces an Investigation of Zosano Pharma Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
Sep-09-16 05:00PM  Zosano Announces Inducement Grant for Georgia Erbez, Chief Business Officer GlobeNewswire
04:20PM  ZOSANO PHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Sep-08-16 08:30AM  Zosano Appoints Georgia Erbez as Chief Business Officer GlobeNewswire
Aug-31-16 02:28PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Shareholders of Zosano Pharma Corporation - ZSAN PR Newswire -13.41%
Aug-29-16 02:11PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Investigation of Zosano Pharma Corporation (ZSAN) Accesswire
Aug-26-16 09:54PM  IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces an Investigation of Zosano Pharma Corporation and Advises Investors With Losses in Excess of $10,000 Contact the Firm Business Wire -14.78%
05:31PM  ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Zosano Pharma Corporation Business Wire
Aug-22-16 11:15PM  Zosano Pharma Corp (ZSAN) President, CEO Konstantinos Alataris Bought $168,153 of Stocks -8.00%
Aug-16-16 09:01AM  ZOSANO PHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements
08:40AM  Zosano Pharma Announces Pricing of Private Placement of Common Stock and Warrants GlobeNewswire
Aug-12-16 12:58PM  IMPORTANT ZOSANO ALERT: Lundin Law PC Announces an Ongoing Investigation of Zosano Pharma Corporation and Advises Investors with Losses In Excess of $10,000 to Contact the Firm Accesswire -8.11%
Aug-11-16 08:02AM  Ladenburg Thalmann Downgrades Zosano Pharma To Neutral On Financing Overhang, Market Uncertainty +6.47%
06:52AM  Zosano Pharma downgraded by Ladenburg Thalmann
Aug-10-16 04:22PM  ZOSANO PHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics to patients suffering from migraine using its Adhesive Dermally-Applied Microarray technology. Its lead product candidate is M207, a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Amzak Capital Management, LLC10% OwnerFeb 27Sale8.265,90148,7600Feb 28 05:38 PM
Amzak Capital Management, LLC10% OwnerFeb 27Sale8.3680,880675,914175,211Feb 28 05:38 PM
Amzak Capital Management, LLC10% OwnerFeb 26Sale11.001,50016,500256,091Feb 28 05:38 PM
GREATHOUSE KENNETHDirectorDec 06Buy0.6155,00033,407200,000Dec 08 04:24 PM
GREATHOUSE KENNETHDirectorDec 01Buy0.6250,00031,080145,000Dec 04 04:05 PM
GREATHOUSE KENNETHDirectorNov 30Buy0.6245,00027,92795,000Dec 04 04:05 PM
GREATHOUSE KENNETHDirectorNov 15Buy0.5815,0008,67550,000Nov 16 05:28 PM
GREATHOUSE KENNETHDirectorNov 14Buy0.6435,00022,48435,000Nov 16 05:28 PM